Interleukin 21 (IL-21) has pleiotropic effects on both cellular and humoral immune responses, such as stimulation of lymphocyte proliferation, promotion of CD8+ T cell and NK cell cytotoxicity, and differentiation of B cells into plasma cells.
MACS GMP Recombinant Human IL-21 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for manufacture of this product. The product is lyophilized without carrier protein or preservatives.
Related products for MACS® GMP Recombinant Human IL-21
Interleukin 21 (IL-21) has pleiotropic effects on both cellular and humoral immune responses, such as stimulation of lymphocyte proliferation, promotion of CD8+ T cell and NK cell cytotoxicity, and differentiation of B cells into plasma cells.
MACS GMP Recombinant Human IL-21 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for manufacture of this product. The product is lyophilized without carrier protein or preservatives.
Biological activity
IL-21 is a four α-helix bundle cytokine and closely related to IL-2, IL-7, and IL-15. IL-21 expression is restricted to activated CD4+ T helper cells and NKT cells. The functional receptor for IL-21, composed of the IL-21 receptor- and the common γ-chain, is expressed on various hematopoietic cells including T, B, NK and dendritic cells.
MACS GMP Recombinant Human IL-21 can be used for a variety of applications, including the ex vivo generation of antigen-specific cytotoxic T cells1,2 or the ex vivo stimulation of NK cells3.
Technical specifications
- Identity/Molecular mass: 15460 Da, determined by mass spectrometry. This corresponds to the mature form of human IL-21 (133 amino acids).
- Purity: ≥ 95 % as determined by chip electrophoresis.
- Endotoxin content: < 100 EU/mg, as determined by kinetic Limulus Amoebocyte Lysate (LAL) assay (Pharmacopoeia Europaea (Ph. Eur.)).
- Residual host cell DNA content: < 20 ng/mg, as determined by quantitative PCR specific for E. coli genomic DNA.
- Residual host cell protein content: < 5 µg/mg, as determined by E. coli HCP ELISA.
The product quality certificate of MACS® GMP Recombinant Human IL-21 was adapted. Learn more here
MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.
MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.
Mass spectrometry analysis (ESI-MS) of MACS GMP Recombinant Human IL-21. The peak corresponds to the calculated molecular mass of 15460 Da.
The biological activity of MACS GMP Recombinant Human IL-21 was determined by a proliferation assay using mouse B9 hybridoma cells.
MACS GMP Recombinant Human IL-21 biological activity. Activity of Human MACS GMP IL-21 (blue bar), was compared to another commercially available product (black bar).
Enter the lot number from your product label to access its Product Quality Certificated (PQC).
- Li, Y. and Yee, C. (2008) IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes. Blood 111: 229-235
- Hinrichs, C. S. et al. (2008) IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 111: 5326-5333
- de Rham, C. et al. (2007) The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res. Ther. 9: R125
You have previously chosen International as your location.
What do you want to do?